SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001491877-12-000022
Filing Date
2012-04-09
Accepted
2012-04-09 16:21:31
Documents
1
Period of Report
2012-04-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3317
  Complete submission text file 0001491877-12-000022.txt   4977
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NABI BIOPHARMACEUTICALS 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address
Kessler Paul D. (Reporting) CIK: 0001428524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 12749873